Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Affinity Asset Advisors, LLC reported a 7.10% stake in Lexeo Therapeutics, Inc. (Schedule 13G/A)

Event Jan 22, 2026 · Filed Jan 29, 2026

Affinity Asset Advisors, LLC reported a 7.10% stake in Lexeo Therapeutics, Inc., 5,217,660 shares, as a passive investor on Jan 22, 2026. Filed Jan 29, 2026 (Schedule 13G/A).

Stake
7.10%
Shares
5,217,660
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC7.10%5,217,660
Michael Cho7.10%5,217,660

Source

View original at SEC

Related